Table 2 Influence of variables on the 90d MoCA value
Variable | Single linear regression | Multiple linear regression | ||
|---|---|---|---|---|
B (95% CI) | p-value | B (95% CI) | p-value | |
MRS ≤ 2 | ||||
Bridging-therapy | 2.01 (0.4–3.62) | 0.015 | 2.39 (0.20–4.58) | 0.033 |
Sex | 0.52 (−1.08–2.12) | 0.526 | ||
Age | −0.11 (−0.17−−0.04) | 0.001 | ||
Symptom-onset to admission | 0.00 (−0.003–0.003) | 0.842 | ||
NIHSS at admission | -0.04 (−0.17–0.09) | 0.551 | ||
Smoking | −1.91 (−3.71--0.11) | 0.038 | ||
Atrial fibrillation | −0.60 (−2.71–1.51) | 0.576 | ||
Aspirin premedication | −0.5 (−2.48–1.49) | 0.623 | ||
Anticoagulation | 1.91 (−1.23–5.05) | 0.232 | ||
ASPECT-Score | −0.25 (− 0.94–0.43) | 0.46 | ||
NIHSS at discharge | −0.09 (− 0.29–0.12) | 0.405 | ||
MRS = 0 | ||||
Bridging-therapy | 3.55 (0.78–6.31) | 0.013 | 4.38 (0.67–8.08) | 0.021 |
Sex | 0.58 (−2.1–3.26) | 0.669 | ||
Age | −0.07 (−0.21–0.07) | 0.319 | ||
Symptom-onset to admission | −0.003 (− 0.76–1.07) | 0.721 | ||
NIHSS at admission | −0.06 (− 0.24–0.13) | 0.56 | ||
Smoking | 0.80 (−2.50–4.11) | 0.63 | ||
Dyslipidemia | 2.49 (−0.28–5.27) | 0.078 | ||
Aspirin premedication | −2.28 (−5.41–0.86) | 0.154 | ||
Anticoagulation | −0.49 (−7.32–6.34) | 0.881 | ||
NIHSS at discharge | 0.16 (−0.76–1.07) | 0.721 | ||